CITIUS PHARMACEUTICALS INC's ticker is and the CUSIP is 17322U907. A total of 3 filers reported holding CITIUS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $233,236 | -43.9% | 340,800 | -1.6% | 0.00% | 0.0% |
| Q2 2023 | $415,800 | +158.8% | 346,500 | +152.4% | 0.00% | 0.0% |
| Q1 2023 | $160,641 | -21.0% | 137,300 | -46.7% | 0.00% | – |
| Q4 2022 | $203,425 | -62.4% | 257,500 | -42.4% | 0.00% | -100.0% |
| Q3 2022 | $541,000 | – | 446,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 46,000 | $70,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |